OPKO Health, Inc. (TLV:OPK)
360.50
-2.10 (-0.58%)
At close: Mar 13, 2026
OPKO Health Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -180.4 | -53.22 | -188.86 | -328.41 | -30.14 | 30.59 |
Depreciation & Amortization | 93.29 | 98.18 | 105.3 | 108.66 | 78.72 | 85.36 |
Stock-Based Compensation | 10.86 | 11.05 | 11.41 | 18.51 | 13.63 | 8.95 |
Other Adjustments | 25.81 | -271.66 | 22.16 | 63.4 | -3.39 | 12.19 |
Change in Receivables | 7.6 | -0.22 | 3.41 | 128.6 | 5.23 | -150.44 |
Changes in Inventories | -7.53 | 4.22 | 15.2 | 13.66 | 30.68 | -77.64 |
Changes in Accounts Payable | -11.29 | -20.66 | 2.83 | -9.39 | -10.85 | 37.16 |
Changes in Accrued Expenses | -40.33 | 48.68 | -5.48 | -91.11 | -33.72 | 81.83 |
Changes in Unearned Revenue | - | - | - | - | -15.91 | -5.39 |
Changes in Other Operating Activities | 5.52 | 0.16 | 5.84 | 0.89 | 4.08 | 16.87 |
Operating Cash Flow | -197.03 | -183.49 | -28.2 | -95.19 | 38.34 | 39.48 |
Operating Cash Flow Growth | - | - | - | - | -2.89% | - |
Capital Expenditures | -15.03 | -25.01 | -16.28 | -24.58 | -32.16 | -33.68 |
Sale of Property, Plant & Equipment | 0.27 | 0.24 | 2.71 | 1.95 | 66.03 | 0.25 |
Purchases of Investments | -7.67 | - | -5 | - | -2 | - |
Proceeds from Sale of Investments | 171.53 | 166.6 | 0.36 | 115.42 | 8.08 | 15.11 |
Payments for Business Acquisitions | - | - | - | -1.76 | -4 | - |
Proceeds from Business Divestments | - | 210.38 | - | - | - | - |
Investing Cash Flow | 348.33 | 352.21 | -18.2 | 91.04 | 35.95 | -18.33 |
Short-Term Debt Issued | 35.48 | 459.43 | 671.68 | 1,060 | 1,685 | 1,108 |
Short-Term Debt Repaid | -37.94 | -475.06 | -679.71 | -1,036 | -1,696 | -1,144 |
Net Short-Term Debt Issued (Repaid) | -2.47 | -15.63 | -8.03 | 23.75 | -11.24 | -35.83 |
Long-Term Debt Issued | - | 480 | - | - | - | - |
Long-Term Debt Repaid | 5.62 | -176.39 | -3 | - | - | - |
Net Long-Term Debt Issued (Repaid) | 5.62 | 303.61 | -3 | - | - | - |
Issuance of Common Stock | -0.12 | -0.21 | -0.27 | -0.77 | 1.08 | 0.76 |
Repurchase of Common Stock | -50 | -90.22 | - | - | - | - |
Net Common Stock Issued (Repurchased) | -50.12 | -90.43 | -0.27 | -0.77 | 1.08 | 0.76 |
Other Financing Activities | -2.41 | -13.39 | - | - | -0.19 | - |
Financing Cash Flow | -140.19 | 184.17 | -11.3 | 22.97 | -10.35 | -35.08 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | -2.3 | -3.16 | 0.39 | -0.34 | -1.44 | 0.69 |
Net Cash Flow | 8.81 | 349.73 | -57.31 | 18.48 | 62.5 | -13.24 |
Free Cash Flow | -212.06 | -208.5 | -44.47 | -119.77 | 6.18 | 5.79 |
Free Cash Flow Growth | - | - | - | - | 6.68% | - |
FCF Margin | -33.03% | -29.24% | -5.15% | -11.93% | 0.35% | 0.40% |
Free Cash Flow Per Share | -0.27 | -0.35 | -0.06 | -0.17 | 0.01 | 0.01 |
Levered Free Cash Flow | -214.81 | 340.32 | -92.48 | -306.53 | -20.54 | 99.26 |
Unlevered Free Cash Flow | -104.34 | 3.1 | -52.9 | -202.32 | 45.8 | 136.58 |
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.